Snap, Inc. Q2 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Social media platform Snap Inc. (NYSE: SNAP) will be publishing results for the second quarter of 2023 today after the...
LATEST
Alphabet Q2 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript
Google parent Alphabet Inc. (NASDAQ: GOOG, GOOGL) is all set to publish second-quarter 2023 earnings today at 4:00 PM ET....
Visa Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript
Some of the top companies are scheduled to report earnings today after markets close, and Visa Inc (NYSE: V) is...
Microsoft Q4 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Software giant Microsoft Corporation (NASDAQ: MSFT) will be publishing its fourth quarter 2023 financial results today after the closing bell....
Netflix Q2 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript
Video streaming giant Netflix, Inc. (NASDAQ: NFLX) is expected to publish its June quarter results today after the closing bell....
IBM Q2 2023 Earnings Call: Listen Live and Get the Real-Time Transcript
Some of the top companies are scheduled to report earnings today, and International Business Machines Corporation (NYSE: IBM) is one...
Tesla Q2 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Electric vehicle maker Tesla Inc. (NASDAQ: TSLA) will be publishing second-quarter 2023 earnings today at 4:05 pm ET. The company...
Ocean Biomedical focuses its malaria program to address chronic malaria crisis in sub-Saharan Africa
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it is focusing its multi-pronged malaria program to address the...
We see public listing as the next logical step in our growth as an organization: CEO of Aeries
Aeries Technology is a global services company providing technology, business process management and transformation services to some of the leading global...
Superlatus names Dr. Eugenio Bortone COO; interim CEO Tim Alford to become CCO
Superlatus, Inc., a holding company of food products and distribution capabilities, on Tuesday, announced new appointments to its management team....
Ocean Biomedical (OCEA) joins the Russell 2000 Index
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has been included in the Russell 2000 Index and the broad-market...
Ocean Biomedical granted US patent for bispecific cancer immunotherapy treatment
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Monday said its scientific co-founder Dr. Jack Elias has been granted a...
Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform
Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be...
Ocean Biomedical extends patent rights for idiopathic pulmonary fibrosis discovery to Europe
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Friday revealed that its scientific co-founder Dr. Jack Elias has received notice...
Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock...
Initial response to single-serve pour-over product is the driver behind NuZee’s business: CEO
NuZee, Inc. (NASDAQ: NUZE) is a leading coffee technology and co-packing company that provides end-to-end sustainable solutions for clients ranging...
Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said...
Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a...
Ocean Biomedical (OCEA) set to join the Russell 2000 Index
Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index,...
Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment
Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad...
Ocean Biomedical announces private placement of $25 mln convertible notes
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a...